AlphaCognition
Alpha Cognition is a clinical stage, biopharmaceutical company developing treatments for neurodegenerative diseases such as Alzheimer’s Dementia and Amyotrophic Lateral Sclerosis (ALS).
CIK Number
Legal Name
Alpha Cognition Inc.
0
Country
Date Incorporated
2014
Email Address
info@alphacognition.com
Founded Date
2014
Latest Funding Round Date
April 2020
Latest Funding Round Amount (USD)
1,915,000
Legal classification
LinkedIn URL
Location
Place of Incorporation
Previous Name
Neurodyn Cognition Inc.
0
Total Funding Amount (USD)
12,251,093
Official Website
Find more companies like AlphaCognition
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.